Welcome - Register - Login - Help/FAQ - 0 items

Search
Enter keywords, a title or
a report id number below.

Advanced


	Select a currency for use throughout the site

Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure

Electronic

Live Chat Live Help Software for Website

Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report

Global Industry Analysts, Inc, Aug 2011, Pages: 279


	Description



		Table of Contents



		Summary



		Companies Mentioned


		Enquire before Buying


		Send to a Friend

This report analyzes the worldwide markets for Overactive Bladder (OAB) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.

The report profiles 34 companies including many key and niche players such as

- Allergan Inc.
- Antares Pharma Inc.
- Apogepha Arzneimittel GmbH
- Astellas Pharma Inc.
- Auxilium Pharmaceuticals Inc.
- Kissei Pharmaceuticals Co. Ltd.
- KYORIN Pharmaceutical Co. Ltd.
- Novartis AG
- Ono Pharmaceutical Co. Ltd.
- Ortho-McNeil-Janssen Pharmaceuticals Inc.
- Pfizer Inc.
- SALVAT Biotech
- Sepracor Pharmaceuticals Inc.
- Watson Pharmaceuticals Inc.

Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying

For enquiries please call us on:

+353-1-415-1241 (GMT Office Hours)

1-917-300-0470 (EST Office Hours)